Intrinsic value of Community Health Systems, Inc. - CYH

Previous Close

$2.98

  Intrinsic Value

$0.00

stock screener

  Rating & Target

str. sell

-100%

Previous close

$2.98

 
Intrinsic value

$0.00

 
Up/down potential

-100%

 
Rating

str. sell

We calculate the intrinsic value of CYH stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.3

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  12.90
  12.11
  11.40
  10.76
  10.18
  9.66
  9.20
  8.78
  8.40
  8.06
  7.75
  7.48
  7.23
  7.01
  6.81
  6.63
  6.46
  6.32
  6.19
  6.07
  5.96
  5.86
  5.78
  5.70
  5.63
  5.57
  5.51
  5.46
  5.41
  5.37
Revenue, $m
  15,981
  17,916
  19,959
  22,106
  24,357
  26,711
  29,168
  31,729
  34,394
  37,166
  40,049
  43,044
  46,156
  49,391
  52,753
  56,249
  59,885
  63,668
  67,606
  71,708
  75,982
  80,438
  85,086
  89,936
  94,999
  100,288
  105,815
  111,591
  117,632
  123,952
Variable operating expenses, $m
  15,666
  17,508
  19,452
  21,496
  23,639
  25,879
  28,218
  30,655
  33,192
  35,831
  38,118
  40,969
  43,931
  47,010
  50,210
  53,537
  56,998
  60,599
  64,347
  68,251
  72,319
  76,560
  80,984
  85,600
  90,420
  95,454
  100,713
  106,212
  111,961
  117,976
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  15,666
  17,508
  19,452
  21,496
  23,639
  25,879
  28,218
  30,655
  33,192
  35,831
  38,118
  40,969
  43,931
  47,010
  50,210
  53,537
  56,998
  60,599
  64,347
  68,251
  72,319
  76,560
  80,984
  85,600
  90,420
  95,454
  100,713
  106,212
  111,961
  117,976
Operating income, $m
  315
  408
  506
  610
  718
  832
  950
  1,074
  1,202
  1,336
  1,931
  2,075
  2,225
  2,381
  2,543
  2,712
  2,887
  3,069
  3,259
  3,457
  3,663
  3,878
  4,102
  4,336
  4,580
  4,835
  5,101
  5,380
  5,671
  5,975
EBITDA, $m
  1,396
  1,565
  1,743
  1,931
  2,127
  2,333
  2,547
  2,771
  3,004
  3,246
  3,498
  3,759
  4,031
  4,314
  4,607
  4,913
  5,230
  5,561
  5,905
  6,263
  6,636
  7,025
  7,431
  7,855
  8,297
  8,759
  9,242
  9,746
  10,274
  10,826
Interest expense (income), $m
  930
  965
  874
  1,012
  1,159
  1,312
  1,473
  1,642
  1,818
  2,001
  2,191
  2,390
  2,596
  2,810
  3,033
  3,265
  3,505
  3,755
  4,015
  4,286
  4,568
  4,862
  5,167
  5,486
  5,819
  6,166
  6,528
  6,907
  7,302
  7,715
  8,148
Earnings before tax, $m
  -651
  -466
  -506
  -549
  -594
  -641
  -691
  -744
  -799
  -856
  -459
  -521
  -585
  -652
  -721
  -794
  -868
  -946
  -1,027
  -1,111
  -1,199
  -1,290
  -1,384
  -1,483
  -1,586
  -1,694
  -1,806
  -1,923
  -2,045
  -2,172
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -651
  -466
  -506
  -549
  -594
  -641
  -691
  -744
  -799
  -856
  -459
  -521
  -585
  -652
  -721
  -794
  -868
  -946
  -1,027
  -1,111
  -1,199
  -1,290
  -1,384
  -1,483
  -1,586
  -1,694
  -1,806
  -1,923
  -2,045
  -2,172

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  17,896
  20,063
  22,350
  24,755
  27,276
  29,912
  32,663
  35,530
  38,515
  41,620
  44,847
  48,201
  51,687
  55,309
  59,074
  62,989
  67,060
  71,297
  75,707
  80,300
  85,087
  90,076
  95,281
  100,712
  106,382
  112,305
  118,493
  124,962
  131,727
  138,804
Adjusted assets (=assets-cash), $m
  17,896
  20,063
  22,350
  24,755
  27,276
  29,912
  32,663
  35,530
  38,515
  41,620
  44,847
  48,201
  51,687
  55,309
  59,074
  62,989
  67,060
  71,297
  75,707
  80,300
  85,087
  90,076
  95,281
  100,712
  106,382
  112,305
  118,493
  124,962
  131,727
  138,804
Revenue / Adjusted assets
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
  0.893
Average production assets, $m
  10,068
  11,287
  12,574
  13,927
  15,345
  16,828
  18,376
  19,989
  21,668
  23,415
  25,231
  27,118
  29,079
  31,116
  33,235
  35,437
  37,727
  40,111
  42,592
  45,176
  47,869
  50,676
  53,604
  56,660
  59,850
  63,182
  66,663
  70,303
  74,108
  78,090
Working capital, $m
  1,310
  1,469
  1,637
  1,813
  1,997
  2,190
  2,392
  2,602
  2,820
  3,048
  3,284
  3,530
  3,785
  4,050
  4,326
  4,612
  4,911
  5,221
  5,544
  5,880
  6,231
  6,596
  6,977
  7,375
  7,790
  8,224
  8,677
  9,150
  9,646
  10,164
Total debt, $m
  12,308
  14,259
  16,317
  18,481
  20,750
  23,122
  25,599
  28,179
  30,866
  33,660
  36,564
  39,583
  42,720
  45,980
  49,369
  52,892
  56,556
  60,369
  64,338
  68,472
  72,780
  77,271
  81,955
  86,843
  91,946
  97,276
  102,846
  108,668
  114,756
  121,125
Total liabilities, $m
  16,106
  18,057
  20,115
  22,279
  24,548
  26,920
  29,397
  31,977
  34,664
  37,458
  40,362
  43,381
  46,518
  49,778
  53,167
  56,690
  60,354
  64,167
  68,136
  72,270
  76,578
  81,069
  85,753
  90,641
  95,744
  101,074
  106,644
  112,466
  118,554
  124,923
Total equity, $m
  1,790
  2,006
  2,235
  2,475
  2,728
  2,991
  3,266
  3,553
  3,852
  4,162
  4,485
  4,820
  5,169
  5,531
  5,907
  6,299
  6,706
  7,130
  7,571
  8,030
  8,509
  9,008
  9,528
  10,071
  10,638
  11,230
  11,849
  12,496
  13,173
  13,880
Total liabilities and equity, $m
  17,896
  20,063
  22,350
  24,754
  27,276
  29,911
  32,663
  35,530
  38,516
  41,620
  44,847
  48,201
  51,687
  55,309
  59,074
  62,989
  67,060
  71,297
  75,707
  80,300
  85,087
  90,077
  95,281
  100,712
  106,382
  112,304
  118,493
  124,962
  131,727
  138,803
Debt-to-equity ratio
  6.880
  7.110
  7.300
  7.470
  7.610
  7.730
  7.840
  7.930
  8.010
  8.090
  8.150
  8.210
  8.270
  8.310
  8.360
  8.400
  8.430
  8.470
  8.500
  8.530
  8.550
  8.580
  8.600
  8.620
  8.640
  8.660
  8.680
  8.700
  8.710
  8.730
Adjusted equity ratio
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -651
  -466
  -506
  -549
  -594
  -641
  -691
  -744
  -799
  -856
  -459
  -521
  -585
  -652
  -721
  -794
  -868
  -946
  -1,027
  -1,111
  -1,199
  -1,290
  -1,384
  -1,483
  -1,586
  -1,694
  -1,806
  -1,923
  -2,045
  -2,172
Depreciation, amort., depletion, $m
  1,081
  1,157
  1,237
  1,321
  1,409
  1,501
  1,597
  1,697
  1,802
  1,910
  1,567
  1,684
  1,806
  1,933
  2,064
  2,201
  2,343
  2,491
  2,645
  2,806
  2,973
  3,148
  3,329
  3,519
  3,717
  3,924
  4,141
  4,367
  4,603
  4,850
Funds from operations, $m
  430
  691
  731
  772
  815
  860
  906
  954
  1,003
  1,055
  1,108
  1,163
  1,221
  1,281
  1,343
  1,407
  1,475
  1,545
  1,618
  1,695
  1,775
  1,858
  1,945
  2,036
  2,131
  2,231
  2,335
  2,444
  2,558
  2,678
Change in working capital, $m
  150
  159
  167
  176
  185
  193
  201
  210
  219
  227
  236
  246
  255
  265
  276
  287
  298
  310
  323
  336
  350
  365
  381
  398
  415
  434
  453
  474
  495
  518
Cash from operations, $m
  281
  532
  563
  596
  631
  667
  704
  744
  785
  827
  872
  918
  966
  1,015
  1,067
  1,121
  1,177
  1,235
  1,295
  1,358
  1,424
  1,493
  1,564
  1,638
  1,716
  1,797
  1,882
  1,970
  2,063
  2,160
Maintenance CAPEX, $m
  -554
  -625
  -701
  -781
  -865
  -953
  -1,045
  -1,141
  -1,242
  -1,346
  -1,454
  -1,567
  -1,684
  -1,806
  -1,933
  -2,064
  -2,201
  -2,343
  -2,491
  -2,645
  -2,806
  -2,973
  -3,148
  -3,329
  -3,519
  -3,717
  -3,924
  -4,141
  -4,367
  -4,603
New CAPEX, $m
  -1,152
  -1,219
  -1,287
  -1,353
  -1,418
  -1,483
  -1,548
  -1,613
  -1,679
  -1,747
  -1,816
  -1,887
  -1,961
  -2,038
  -2,118
  -2,202
  -2,291
  -2,383
  -2,481
  -2,584
  -2,693
  -2,807
  -2,928
  -3,056
  -3,190
  -3,332
  -3,482
  -3,639
  -3,806
  -3,981
Cash from investing activities, $m
  -1,706
  -1,844
  -1,988
  -2,134
  -2,283
  -2,436
  -2,593
  -2,754
  -2,921
  -3,093
  -3,270
  -3,454
  -3,645
  -3,844
  -4,051
  -4,266
  -4,492
  -4,726
  -4,972
  -5,229
  -5,499
  -5,780
  -6,076
  -6,385
  -6,709
  -7,049
  -7,406
  -7,780
  -8,173
  -8,584
Free cash flow, $m
  -1,425
  -1,312
  -1,424
  -1,538
  -1,653
  -1,770
  -1,889
  -2,011
  -2,136
  -2,265
  -2,398
  -2,536
  -2,680
  -2,829
  -2,984
  -3,146
  -3,315
  -3,492
  -3,677
  -3,871
  -4,075
  -4,288
  -4,512
  -4,747
  -4,993
  -5,252
  -5,524
  -5,810
  -6,109
  -6,424
Issuance/(repayment) of debt, $m
  -1,288
  1,950
  2,058
  2,164
  2,269
  2,373
  2,476
  2,581
  2,686
  2,794
  2,905
  3,019
  3,137
  3,260
  3,389
  3,523
  3,664
  3,813
  3,969
  4,134
  4,308
  4,491
  4,684
  4,888
  5,103
  5,330
  5,570
  5,822
  6,088
  6,369
Issuance/(repurchase) of shares, $m
  3,975
  683
  735
  789
  846
  905
  967
  1,031
  1,097
  1,166
  782
  856
  934
  1,014
  1,098
  1,185
  1,276
  1,370
  1,468
  1,570
  1,677
  1,789
  1,905
  2,026
  2,153
  2,286
  2,424
  2,569
  2,721
  2,880
Cash from financing (excl. dividends), $m  
  2,687
  2,633
  2,793
  2,953
  3,115
  3,278
  3,443
  3,612
  3,783
  3,960
  3,687
  3,875
  4,071
  4,274
  4,487
  4,708
  4,940
  5,183
  5,437
  5,704
  5,985
  6,280
  6,589
  6,914
  7,256
  7,616
  7,994
  8,391
  8,809
  9,249
Total cash flow (excl. dividends), $m
  1,263
  1,321
  1,369
  1,416
  1,462
  1,508
  1,554
  1,600
  1,647
  1,695
  1,288
  1,339
  1,391
  1,446
  1,503
  1,562
  1,625
  1,691
  1,760
  1,833
  1,910
  1,992
  2,077
  2,168
  2,263
  2,364
  2,470
  2,582
  2,700
  2,824
Retained Cash Flow (-), $m
  -3,975
  -683
  -735
  -789
  -846
  -905
  -967
  -1,031
  -1,097
  -1,166
  -782
  -856
  -934
  -1,014
  -1,098
  -1,185
  -1,276
  -1,370
  -1,468
  -1,570
  -1,677
  -1,789
  -1,905
  -2,026
  -2,153
  -2,286
  -2,424
  -2,569
  -2,721
  -2,880
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -2,713
  638
  634
  626
  616
  603
  587
  570
  550
  529
  506
  482
  457
  431
  405
  377
  349
  321
  292
  263
  233
  203
  172
  141
  110
  78
  46
  13
  -21
  -56
Discount rate, %
  15.50
  16.28
  17.09
  17.94
  18.84
  19.78
  20.77
  21.81
  22.90
  24.05
  25.25
  26.51
  27.84
  29.23
  30.69
  32.22
  33.83
  35.53
  37.30
  39.17
  41.13
  43.18
  45.34
  47.61
  49.99
  52.49
  55.11
  57.87
  60.76
  63.80
PV of cash for distribution, $m
  -2,349
  472
  395
  324
  260
  204
  157
  118
  86
  61
  43
  29
  19
  12
  7
  4
  2
  1
  1
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  50.0
  36.2
  26.5
  19.6
  14.6
  11.0
  8.3
  6.3
  4.8
  3.7
  3.1
  2.6
  2.2
  1.8
  1.5
  1.3
  1.1
  0.9
  0.7
  0.6
  0.5
  0.4
  0.3
  0.3
  0.2
  0.2
  0.2
  0.1
  0.1
  0.1

Community Health Systems, Inc. is an operator of general acute care hospitals and outpatient facilities in communities across the country. The Company operates through hospital operations segment, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services. The Company provides healthcare services through the hospitals that it owns and operates and affiliated businesses in non-urban and selected urban markets throughout the United States. The services provided through its hospitals and affiliated businesses include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. The Company also provides additional outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers, ambulatory surgery centers, and home health and hospice agencies.

FINANCIAL RATIOS  of  Community Health Systems, Inc. (CYH)

Valuation Ratios
P/E Ratio -0.2
Price to Sales 0
Price to Book 0.2
Price to Tangible Book
Price to Cash Flow 0.3
Price to Free Cash Flow 0.9
Growth Rates
Sales Growth Rate -5.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -21.9%
Cap. Spend. - 3 Yr. Gr. Rate 3.9%
Financial Strength
Quick Ratio 1
Current Ratio 0.2
LT Debt to Equity 915.7%
Total Debt to Equity 943.9%
Interest Coverage -1
Management Effectiveness
Return On Assets -3.5%
Ret/ On Assets - 3 Yr. Avg. 0.9%
Return On Total Capital -9.1%
Ret/ On T. Cap. - 3 Yr. Avg. -2.6%
Return On Equity -61.1%
Return On Equity - 3 Yr. Avg. -18.2%
Asset Turnover 0.8
Profitability Ratios
Gross Margin 83.7%
Gross Margin - 3 Yr. Avg. 84.2%
EBITDA Margin 1.7%
EBITDA Margin - 3 Yr. Avg. 9.1%
Operating Margin -4.8%
Oper. Margin - 3 Yr. Avg. 2.9%
Pre-Tax Margin -9.3%
Pre-Tax Margin - 3 Yr. Avg. -1.8%
Net Profit Margin -9.3%
Net Profit Margin - 3 Yr. Avg. -2.7%
Effective Tax Rate 6.1%
Eff/ Tax Rate - 3 Yr. Avg. 19.4%
Payout Ratio 0%

CYH stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CYH stock intrinsic value calculation we used $14155 million for the last fiscal year's total revenue generated by Community Health Systems, Inc.. The default revenue input number comes from 0001 income statement of Community Health Systems, Inc.. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CYH stock valuation model: a) initial revenue growth rate of 12.9% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 15.5%, whose default value for CYH is calculated based on our internal credit rating of Community Health Systems, Inc., is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Community Health Systems, Inc..
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CYH stock the variable cost ratio is equal to 98.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for CYH stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 7.1% for Community Health Systems, Inc..

Corporate tax rate of 27% is the nominal tax rate for Community Health Systems, Inc.. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CYH stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CYH are equal to 63%.

Life of production assets of 16.1 years is the average useful life of capital assets used in Community Health Systems, Inc. operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CYH is equal to 8.2%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $-1535 million for Community Health Systems, Inc. - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 116.227 million for Community Health Systems, Inc. is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Community Health Systems, Inc. at the current share price and the inputted number of shares is $0.3 billion.

RELATED COMPANIES Price Int.Val. Rating
HCA HCA Healthcare 126.10 44.91  str.sell

CONTACT US      

About X-FIN       Privacy policy       Terms of use      

Copyright © X-FIN.com 2005-2019. All rigths reserved.